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osting by EAbstract This work was carried out to study the protective role of vitamin B12 on the induced
cytotoxicity and genotoxicity of ionizing radiation on male mice, as assessed using micronucleus
technique and by analyzing the morphological abnormalities of spermatozoa.
Male mice were injected intramuscularly with vitamin B12, at a dose of 0.8 mg/kg body weight,
1 h prior to a whole body exposure to 2 Gy gamma irradiation, followed by 2 Gy as a challenged
dose. Animals were sacriﬁced 6, 24, 72 h post-irradiation. The frequency of micronucleated poly-
chromatic erythrocytes (PCEs), normochromatic erythrocytes (NCEs), the ratio of PCEs/NCEs
and mitotic index (MI) of bone marrow cells and sperm, head and tail abnormalities, were evalu-
ated. Administration of vitamin B12 pre-irradiation resulted in a signiﬁcant inhibition in the fre-
quency of radiation induced MNPCE and MNNCE as well as in the ratio of PCEs/NCEs and
MI of bone marrow cells and a signiﬁcant amelioration in sperm head and tail abnormalities.
The results suggested that vitamin B12 in a dose of 0.8 mg/kg body weight plays a protective role
when administered prior to irradiation.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.ology Department, Faculty of
x 22452, Riyadh 11495, Saudi
(O.H.M. El-Habit).
y. Production and hosting by
Saud University.
lsevier1. Introduction
Dietary vitamin supplementation is an emerging trend, with the
consumption of vitamins dramatically increasing. This increase
can be attributed partially to an increased awareness of the
function of micronutrients in the body and the role they appear
to have in maintaining general health and treating disease. Sup-
plements are widely available, and marketing of vitamins has
developed into a considerable consumer industry largely driven
by the media (Rowe andToner, 2008; Woodside et al., 2005). A
large number of micronutrients as (vitamins, essential minerals
and other compounds required in small amounts for normal
metabolism) are required in the human diet (Saltman et al.,
1993).
198 R.S. Al-Meer et al.Folic acid and vitamin B12 play an important role in
DNA metabolism (Eto and Krumdieck, 1986). Folic acid
and vitamin B12 are also required for the synthesis of methi-
onine and S-adenosyl methionine, the common methyl donor
required for the maintenance of methylation patterns in
DNA that determine gene expression and DNA conforma-
tion (Eto and Krumdieck, 1986). Deﬁciencies in folic acid
and vitamin B12 therefore lead to, elevated DNA damage
rate and altered methylation of DNA, both of which are
important risk factors for cancer and an increased level in
homocysteine (HC) status is an important risk factor of
cardiovascular diseases (Zingg and Jones, 1997).These same
defects may also play an important role in development
and leads to neurological abnormalities. The blood levels
of folate and vitamin B12 required to prevent anemia and
hyperhomocysteinemia are properly deﬁned, however it is
still uncertain whether such accepted levels of sufﬁciency
are in fact adequate to minimize chromosome damage rate
and optimize DNA methylation status (Wilson and Jones,
1983). A series of studies to investigate the interrelationship
between DNA damage in somatic cells and blood status
for folate, vitamin B12 and HC were carried out (Fenech,
2003).
The importance of identifying dietary factors that minimize
DNA damage rate is underscored by recent evidence from two
epidemiological prospective studies indicating that a reduced
level of chromosome damage in lymphocytes is a relevant bio-
marker of reduced future cancer risk, (Fenech et al., 1998;
Hagmar et al., 1994). Most studies have considered the com-
bined effect of both folic acid and vitamin B12, while the sole
effect of vitamin B12 has been addressed in few epidemiological
studies on men. Preliminary studies in young men (Fenech
et al., 1998), indicated that there was a signiﬁcant negative cor-
relation between the micronucleus frequency in lymphocytes
and plasma vitamin B12 status. Results from studies in men
aged 50–70 years (Bonassi et al., 1995), have shown that the
micronucleus index correlates negatively with vitamin B12 in
subjects who are not vitamin B12 deﬁcient and that the micro-
nucleus index is signiﬁcantly and positively correlated with
plasma HC status in men who are not folate or vitamin B12
deﬁcient. These studies suggested that the plasma levels of
HC and vitamin B12 that correspond to minimization of
chromosome damage require better deﬁnition. The ﬁrst study
reporting the interrelationship of chromosome damage rate,
DNA methylation, HC, folate and vitamin B12 status in young
Australians was reported (Fenech et al., 1998). No experimen-
tal controlled study on the protective role of vitamin B12 has
been reported. The mammalian in vivo micronucleus assay is
widely used as part of the genotoxicity testing battery required
during the development of new drugs (Fenech, 2000; Wyrobek
et al., 1984).
Sperms are important target cells in reproductive toxicol-
ogy for assessment of spermatogenic damage, fertility and
heritable genetic mutations (Krzanowska, 1976; Adler, 1977).
Although not widely used in mutagenicity testing, the sperm
morphology test proves to be a sensitive one. Sperm tests have
also been used to study chemically induced sperm – mutagenic
dysfunction in other mammalian species, including humans
(Adler, 1977).
Two lines of evidence suggest that induce changes in sperm
morphology reﬂect genetic damage in male germ cell. First,
considerable evidence indicates that sperm shaping is polyge-netically controlled by numerous autosomal and sex-linked.
Second, all mouse germ cell mutagens (including ionizing radi-
ations) so far tested in the mouse sperm morphology test
showed positive responses. This observation is based on com-
parison of the ability of chemical agents of induced abnormal
shaped sperm besides inducing dominant lethal, heritable
translocations, and speciﬁc locus mutations (Bruce and
Heddle, 1979).
This study was carried out to evaluate the role of vitamin
B12 on radiation induced cytotoxicity and genotoxicity.2. Materials and methods
2.1. Experimental animals
Swiss albino mice, strain SWR/J, were used in these studies.
Adult Swiss albino male mice were obtained from the Central
Animal House of King Saud University (Womens Branch –
Malaz, Riyadh, KSA). Animals were maintained in hygienic
conditions with good ventilation and under normal tempera-
tures and humidity. Food and water were provided ad libitum.
Male mice were used in order to avoid hormonal interference
in females during the different stages of the estrous cycle. All
animals were from 10 to 12 weeks of age with an approximate
body weight of 25 g, and were randomly selected for experi-
mental and control series.
Animals were divided into six groups, each of 20 mice.
Group 1: animals served as control, received no treatment.
Group 2: animals received a whole body exposure of gamma
rays at a dose of 2.0 Gy. Group 3: animals were injected i.m.
with a single dose of vitamin B12 (Vit. B12) (0.8 mg/kg body
weight). Group 4: animals were injected i.m. with a single
dose of Vit. B12. One hour before exposure to a dose of
2.0 Gy of gamma radiation. Group 5: animals were exposed
to an initial dose of 2 Gy gamma radiation followed after
6.0 h with a second challenge dose of 2.0 Gy. Group 6: ani-
mals were treated in the same way as group 5 except for
being injected i.m. with Vit. B12 (0.8 mg/kg body weight)
1 h. before the second challenging dose of gamma radiation.
Mice (n= 5) were sacriﬁced (0 h) 1 h after the ﬁrst dose of
radiation and 6, 24 and 72 h post the challenge dose of radia-
tion or post-treatment with vitamin B12.
Irradiation was carried out using Cobalt-60 source
(Gamma cell 220-Nordion International Inc., Kanata, Can-
ada) At Research Center of King Saud University, Faculty
of Science, Riyadh, KSA.
Each animal received a whole body exposure of 2 Gy and
additional 2 Gy (challenged dose) at a dose rate of 0.667 Gy/
min.
Both femurs were removed and bone marrow was extracted
for cytogenetic analysis and sperm samples for sperm head and
tail abnormalities.
2.2. Vitamin B12 toxicity
Vitamin B12 was purchased from sigma and dissolved in saline,
and given to animals by intramuscular injection.
Five groups of male mice, each consisted of 10 animals were
used to assess the toxicity of Vit. B12. One group served as con-
trol and the other groups each received one of the following
doses of Vit. B12: 0.8, 1.2, 1.6 or 1.8 mg/kg body weight in-
Adaptive response to ionizing radiation and the role of vitamin B12 199jected i.m. daily for three consecutive weeks. The animals were
observed for any signs of health deterioration or mortality and
the results were recorded.
2.3. Cytogenetic analysis (micronucleus MN assay) (Schmid,
1975, 1982; Heddle et al., 1983)
Bone marrow smears were prepared and allowed to dry over-
night. Differential staining to distinguish polychromatic eryth-
rocytes (PCE) and normochromatic erythrocytes (NCE) with
May-Gruenwald and Giemsa stains were preformed.
The polychromatic erythrocytes (PCEs) stained bluish pur-
ple due to their high content of RNA in the cytoplasm. The nor-
mochromatic erythrocytes (NCEs) stained orange-yellow and
were slightly smaller than PCEs. The micronuclei (MNs) were
recognized as deep purple stained bodies in the cytoplasm.
Five hundred PCEs and the number of MNPCEs were
counted for each individual mouse using 100· (oil immersion).
The number of NCEs was also counted in the ﬁelds of recorded
PCEs and scored for MNs and the ratio of PCE/NCE was
determined. The data from individual animals were reported
as presented in Figs. 3–5.
2.4. Morphological abnormalities of spermatozoa (Wyrobek
et al., 1984; Krzanowska, 1976; Wyrobek and Bruce, 1975)
This experiment was carried out to evaluate the effect of
vitamin B12 and gamma radiation on the morphological
changes of sperm head and tail abnormalities.
2.4.1. Slide preparation and staining
Slides made by placing one drop of the solutions on a slide,
and spreading by three passes of another slide then they air
dried. Then, the slides were stained with 1% Eosin (Sigma)
for 10–15 min, and differentiated in distilled water.
2.4.2. Microscopic analysis and data recording
One thousand spermatozoa from each animal were counted
from different ﬁelds. The percentages of abnormal sperm were
calculated. Sperm with abnormal morphology were catego-
rized into sperm with head and tail abnormality. The data
from each individual animal was reported and tabulated.0%
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Figure 1 The percentage of mortalit2.5. Statistical analysis of data
Student’s t-test was applied for the statistical analysis of the
cytogenetic results (Byrkit, 1980).3. Results
3.1. Lethality and toxicity studies
These studies determined the optimum dose of vitamin B12 with
no apparent toxic effect. Four different doses were investigated:
0.8, 1.2, 1.6, 1.8 mg/25 kg body weight, animals used weights
(20–25 g) injected intramuscular for three consecutive weeks.
The results demonstrate that treatment of mice with vita-
min B12 at the previous indicated doses caused no death during
30 days after administration of the last dose. No signiﬁcant
changes were observed in body weights also no morphological
changes during the whole experiments.
The results in (Fig. 1) demonstrate the percentage of mor-
tality rate in different animal groups. The dose equivalent to
the human is 0.8 mg/kg g body weight injected intramuscularly
1 h before irradiation with 2 Gy, in addition to another group
pre-treated with vitamin B12 and irradiated with an additional
dose of 2 Gy.
The results demonstrate that 2 Gy irradiation showed a
mortality rate of 16.6%, 50%, 66.6% and 66.6% at 7, 14, 21;
28 days post-irradiation, respectively. While the vitamin B12
pre-treated group showed a mortality rate of 0%, 33.3%,
50%, and 50%, respectively, at 0 h.
Results of 2 Gy additional dose demonstrate that irradia-
tion of mice increased the percentage of mortality to 40%,
72.2%, 83.3% and 100% at 7, 14, 21, 28 days, respectively,
post-irradiation, while the group pre-treated with Vit. B12
(0.8 mg/kg body weight) pre-irradiation, resulted in a mortality
rate of 27.7%, 50%, 66.6%, and 83.3% at the same experimen-
tal times, which indicate a lower mortality rate of about 12.3%,
22.2% and 16.7% and 16.7% at 7, 14, 21 and 28, respectively.
Results of observation of the surviving animals in the irra-
diated groups revealed that all animals showed irritated nose,
ears, loss of hair, swollen feet and lesioned tails. While the
groups pre-treated with Vit. B12 (0.02 mg/25 g body weight)4 days 21 days 28 days
st irradaition
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Figure 2 Percentage of mitotic index (% MI) of bone marrow cells in different groups of mice assessed at 0, 6, 24 and 72 h.
200 R.S. Al-Meer et al.before irradiation, were normal, and did not show any symp-
toms of sickness.
The results obtained indicated that the optimum radio-
protective action of Vit. B12, against mortality and morpholog-
ical changes induced by whole body gamma irradiation was at
day 14.
3.2. Effect of vitamin B12 and gamma radiation on cytogentic
parameters (mitotic index MI)
The control for 2 Gy at 0 h showed a mitotic index of 49.82%
assessed at 0, 6, 24 and 72 h, while Vit. B12 pre-treated group
revealed a mitotic index ranging between 47.22% and 50%.
No signiﬁcant changes were noted between Vit. B12 pre-treated
group and the control at different time intervals (P1 > 0.05).
The frequency of the changes in the mitotic index for the
irradiated group was 32.9% at 0 h, which indicates a highly
signiﬁcant delay (P1 < 0.001) in the MI compared to the con-
trol group. While the irradiated group pre-treated with Vit. B12
showed a highly signiﬁcant delay (P2 < 0.001) in the mitotic
index, compared to Vit. B12 pre-treated groups, but less than
the effect induced by irradiation alone. Pre-treatment of the
irradiated group with vitamin B12, resulted in relative remark-
able recovery of about 15.7%, (P3 < 0.001) when compared to
the irradiated group at 0, 6, 24 and 72 h. The additional chal-
lenged dose of 2 Gy resulted in a highly signiﬁcant delay in the
mitotic indices compared to the data obtained from control
group at 6, 24 and 72 h. Also, pre-treated Vit. B12 irradiated0
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Figure 3 Changes of the percentage of MNPCEs of bone marrowgroups showed a relative recovery of about 22.7%, 19.8%
and 22.6% at 6, 24 and 72 h, respectively, when compared to
the irradiated group reaching its maximum at 6 and 72 h
(Fig. 2).
4. Induction of micronuclei
4.1. The frequency of micronuclei in polychromatic erythrocytes
(MNPCEs)
The MNPCEs, MNNCEs and the ratio of PCEs/NCEs data
obtained from bone marrow smears are presented in (Figs.
3–5).
4.2. The frequency of micronuclei in normochromatic
erythrocytes (MNNCEs)
4.2.1. The changes in the ratios of polychromatic erythrocytes to
normochromatic erythrocytes (PCEs/NCEs)
Comparison of the control and Vit. B12 treated groups showed
no signiﬁcant differences in the percentage of total MNPCE at
different assay times. The irradiated group showed a signiﬁ-
cant increase in PCEs compared with both control and Vit.
B12 treated groups. The differences increased steadily to reach
3-folds by 72 h. The frequency of PCEs with more than one
MN was even higher than 3-folds suggesting that cells with
one MN are more liable to more damage than non-affected
cells.24 hr (+ 2 Gy ) 72 hr (+ 2 Gy )
ay Time
ated Vitamin B12 pre irradiation
cells in different groups of mice assessed at 0, 6, 24 and 72 h.
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Figure 4 Changes of the percentage of MNNCEs of bone marrow cells in different groups of mice assessed at 0, 6, 24 and 72 h.
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Figure 5 Changes in the ratio of PCEs to NCEs of bone marrow cells in different groups of mice assessed at 0, 6, 24 and 72 h.
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in a signiﬁcant reduction in the percentage of MNPCEs to
about 35–45% of those values induced by irradiation alone
at 24 and 72 h, respectively. The frequency of MNNCEs was
greatly increased by exposure to 2 Gy and the increase was
time dependents it reached almost 3-folds by 72 h. Pre-
treatment of irradiated groups with Vit. B12 caused signiﬁ-
cantly less damage and resulted in a much lower frequency
of MNPCEs which reached about 50% of those inﬂected by
radiation alone. The PCE/NCE ratio was similar between
the control and Vit. B12 treated groups. Irradiation resulted
in a signiﬁcant decrease in PCE relative to NCE. Pre-treatment
with Vit. B12, resulted in a moderate decrease of PCEs relative
to NCE.
4.3. Effect of vitamin B12 and gamma radiation and their
combination on sperm head and tail abnormalities
The frequencies of sperm head and tail abnormalities of mice
from control; vitamin B12; irradiated group to a priming dose
of 2 Gy c-irradiation and vitamin B12 pre-treated irradiated
group, assessed at 0 h are illustrated in (Fig. 6A).
The data from irradiated group to an additional (challenge
dose) of 2 Gy, and a group of mice pre-treated with vitamin
B12 and irradiated to the challenge dose of 2 Gy were com-
pared with the non-treated (control) and vitamin B12 group,
and assessed at 6, 24 and 72 h, are illustrated in (Fig. 6B–D).
The results suggests that, there is an increase in the frequencies
of total abnormal sperm, reaches its maximum at 72 h assay
time post-irradiation (21.3%) at the group of mice exposedto the additional challenge dose of 2 Gy and 13.3% and
17.3% when assessed at 6 and 24 h, respectively, which indi-
cates an increment with the time of assessment post-irradia-
tion. The total frequency of abnormal sperm was 9.7% for
the group of mice exposed to a priming dose of 2 Gy only
and assessed at 0 h. It means that time plays an important fac-
tor in increasing the incidence of total abnormal sperm with
increasing the dose.
Pre-treatment with vitamin B12 resulted in a decrease in the
frequency of the total abnormal sperm and the differences
were very highly signiﬁcant (P3 < 0.001) when compared to
the irradiated groups at all assay time, and a highly signiﬁcant
changes (P3 < 0.01) in the total number of sperm with amor-
phous head and abnormal tail noted only at 24 and 72 h of the
assay time (Fig. 6). Pre-treatment with vitamin B12 prior to
irradiation resulted in a decrease in the total abnormal sperm
by 1.3-folds, and 1.5-, 1.3- and 1.4-folds for the total abnormal
head. A decrease by 1.1-, 1.2- and 1.3-folds were noted in the
total sperm with abnormal tail when compared with irradiated
groups and assessed at 6, 24 and 72 h, respectively. The types
of abnormalities scored were mainly head without hook, amor-
phous head and abnormal tail (Plate 1a–f).
5. Discussion
It is well documented that ionizing radiation increased the inci-
dence of MN in vivo (Salvadori et al., 1996). In the present
study, whole body gamma irradiation of mice raised the inci-
dence of MNPCEs very signiﬁcantly. The MNPCE that ap-
peared in case of mice represents erythroblasts in G2 phase
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Figure 6 (A–D) Effect of gamma rays in the percentages of sperm head and tail abnormalities in different groups of mice assessed at 0, 6,
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202 R.S. Al-Meer et al.of the cell cycle during irradiation, while the ones that
appeared may be at the G1/S phase of the cell cycle. During
irradiation both hydrogen peroxide and hydroxyl free radicalsPlate 1 Effect of gamma rays on the frequencies of sperm head and
and 72 h.are found within the cell which can directly or indirectly cause
DNA damage (Fenech, 2000, 2002). The radio-protective ef-
fect of vitamin B12 was assessed in this study by estimatingtail abnormalities in different groups of mice, assessed at 0, 6, 24,
Adaptive response to ionizing radiation and the role of vitamin B12 203the frequency of induced MN in PCEs and NCEs of bone
marrow in vivo. The protective action of vitamin B12 against
Gamma irradiation depends on the dose and rate of exposure.
Vitamin B12 plays an important role in DNA metabolism
(Hultdin et al., 2005) and it is also required for the synthesis
of methionine and S-adenosyl methionine, the common methyl
donor required for the maintenance of methylation patterns in
DNA that determine gene expression and DNA conformation
(Zingg and Jones, 1997). It has also been reported that vitamin
B12 plays an important protective role in cervical carcinogene-
sis (Hernandez et al., 2003) and an effective role in patients
with rheumatoid arthritis (Hornung et al., 2004).
In this study, the administration of Vit. B12 did not alter the
incidence of MN of PCEs and NCEs. However the pre-treat-
ment of irradiated group with vitamin B12 at different time
intervals showed a very signiﬁcant decrease in the frequency
of MNNCEs. Similar results (Fenech et al., 1998) were re-
ported, where Vit. B12 caused a signiﬁcant decrease in the
MN of NCEs induced by Gamma rays (Fenech and Rinaldi,
1994; Fenech et al., 1997; El-Habit et al., 2000; Mortazavi
et al., 2003). The ratio of PCEs to MNCEs decreased signiﬁ-
cantly at 6 and 72 h post-irradiation. This was due to a decline
in the number of PCEs relative to NCEs in the bone marrow
after irradiation. Pre-treatment with Vit. B12 prior to irradia-
tion reestablished the relative proportion of PCEs/NCEs. Pro-
tection of bone marrow tissue by Vit. B12 against radiation
toxicity is expressed as an increase in the ratio of PCEs/NCEs
(Salvadori et al., 1996).
Sperm DNA damage has been associated with high levels of
reactive oxygen species which have been detected in the semen
of 25% of infertile men (Irvine et al., 2000; Oliva, 2006).
Although low levels of reactive oxygen species are necessary
for normal sperm functions, high levels are generated by defec-
tive spermatozoa and by semen leukocytes, which results in
sperm dysfunction.
The association between sperm DNA damage and sperm
derived reactive oxygen species suggests that DNA damage
may be caused by a defect in spermatogenesis (Gomez et al.,
1996), whereas the association between sperm DNA damage
and leukocyte-derived reactive oxygen species suggests that
DNA damage may be caused by a post-testicular defect
(Ochsendorf, 1999; Zhang et al., 2008).
In this study, sperm abnormalities are used to measure the
mutagenic effect in the germ cells of mice treated with Vit. B12,
irradiated and pre-treated with Vit. B12, irradiated with a dose
of 2 Gy of c-rays and to an additional challenged dose of 2 Gy
and assessed at 0, 6, 24 and 72 h.
The signiﬁcant increase in sperm shape abnormalities may
reﬂect chromosome abnormalities in primary spermatocytes
and spermatids, and has always been associated with infertility
(Wyrobek and Bruce, 1978; Wyrobek et al., 1984).
Two lines of evidence suggest that induced changes in
sperm morphology reﬂect genetic damage in the male germ
cell. First, considerable evidence indicate that sperm shaping
is poly genetically controlled by numerous autosomal and
sex-linked abnormalities. Secondly, effects of all the mouse
germ cell mutagens (including ionizing radiations) so far tested
on the mouse sperm morphology showed positive responses.
This observation is based on comparison of the ability of
chemical agents to induce abnormal sperms morphology be-
sides inducing dominant lethal, heritable translocations, and
speciﬁc locus mutations (Adler, 1977; Wyrobek et al., 1984).The protective role of vitamin B12 against the induced morpho-
logical changes in sperm morphology was represented in the
data of the Vit. B12 pre-treated irradiated groups of mice.
The data obtained demonstrated a deﬁnite and pronounced
clastogenic effect of ionizing radiation on the mouse bone mar-
row cells represented by induction of micronuclei and sperm
head and tail abnormalities. However, a modulatory effect
was noted in Vit. B12 pre-treated irradiated groups, which sug-
gest that Vit. B12 alone is likely to be one of the most impor-
tant micronutrients which exert a vital protective role against
gamma irradiation.
The priming dose may be as large as 2 Gy and would have
the same effect as the small doses. Therefore, it may have the
capacity of inducing a radio-adaptive response as the effect of
the larger doses. The intake of antioxidants as supplements in
the diet will confer greater protection against potential damage
incurred by exposure to radiations or other environmental
hazards.
Splitting of radiation dose could have the same effect as the
initial priming dose and the subsequent challenge dose in con-
ferring adaptive responses by the initial dose as recently re-
ported (Zhang et al., 2008). The results suggest that the
priming dose can be as large as 2.0 Gy using an animal model.Acknowledgements
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